HLTRF
Price:
$2.43
Market Cap:
$77.26M
HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular (CV) markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic used in the treatment of schizophrenia; Vascepa, an icosapent ethyl capsules; and PERSERIS, an injectable risperidone product for the treatment of schizophrenia. It also offers MyCare psychiatry lab assays and MyCare Insite point of care therapeutic drug-level monitoring tests. In addition, the company holds the U.S. marketing rights of Absorica, a commercial stage dermatology product; ...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2010-01-27
Stock Exchange
PNK
Ticker
HLTRF
According to HLS Therapeutics Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.52. This represents a change of -24.49% compared to the average of -4.66 of the last 4 quarters.
The mean historical PE Ratio of HLS Therapeutics Inc. over the last ten years is -18.71. The current -3.52 PE Ratio has changed 1.78% with respect to the historical average. Over the past ten years (40 quarters), HLTRF's PE Ratio was at its highest in in the March 2020 quarter at 680.69. The PE Ratio was at its lowest in in the June 2015 quarter at -156.03.
Average
-18.71
Median
-15.51
Minimum
-51.12
Maximum
2.78
Discovering the peaks and valleys of HLS Therapeutics Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 178.07%
Maximum Annual PE Ratio = 2.78
Minimum Annual Increase = -761.09%
Minimum Annual PE Ratio = -51.12
Year | PE Ratio | Change |
---|---|---|
2023 | -4.50 | -54.84% |
2022 | -9.96 | -64.81% |
2021 | -28.31 | -1.13% |
2020 | -28.64 | 0.49% |
2019 | -28.50 | 125.54% |
2018 | -12.64 | 62.49% |
2017 | -7.78 | -84.79% |
2016 | -51.12 | 178.07% |
2015 | -18.38 | -761.09% |
2014 | 2.78 | -40.14% |
The current PE Ratio of HLS Therapeutics Inc. (HLTRF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-14.26
5-year avg
-19.98
10-year avg
-18.71
HLS Therapeutics Inc.’s PE Ratio is less than Aion Therapeutic Inc. (-0.51), less than Cipher Pharmaceuticals Inc. (16.86), less than Cannara Biotech Inc. (11.32), greater than Knight Therapeutics Inc. (-16.79), less than Canntab Therapeutics Limited (-0.00), greater than Bionoid Pharma Inc. (-406.16), greater than Crescita Therapeutics Inc. (-4.42), greater than CENTR Brands Corp. (-5.38), less than RAMM Pharma Corp. (0), less than Craftport Cannabis Corp. (-0.01), less than Speakeasy Cannabis Club Ltd. (-0.00), less than City View Green Holdings Inc. (-3.00), less than RavenQuest BioMed Inc. (-0.00), less than Lowell Farms Inc. (-0.01),
Company | PE Ratio | Market cap |
---|---|---|
-0.51 | $5.08M | |
16.86 | $271.76M | |
11.32 | $38.30M | |
-16.79 | $383.05M | |
-0.00 | $147.02K | |
-406.16 | $9.75M | |
-4.42 | $8.61M | |
-5.38 | $1.35M | |
0 | $15.16M | |
-0.01 | $6.46B | |
-0.00 | $1.31K | |
-3.00 | $3.75M | |
-0.00 | $482.11K | |
-0.01 | $272.25K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like HLS Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like HLS Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is HLS Therapeutics Inc.'s PE Ratio?
How is the PE Ratio calculated for HLS Therapeutics Inc. (HLTRF)?
What is the highest PE Ratio for HLS Therapeutics Inc. (HLTRF)?
What is the 3-year average PE Ratio for HLS Therapeutics Inc. (HLTRF)?
What is the 5-year average PE Ratio for HLS Therapeutics Inc. (HLTRF)?
How does the current PE Ratio for HLS Therapeutics Inc. (HLTRF) compare to its historical average?